New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BMY;PMFG;FB From The Last 14 Days
Check below for free stories on BMY;PMFG;FB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 27, 2014
10:02 EDTFBActive equity options trading on open
Subscribe for More Information
09:53 EDTBMYOn The Fly: Analyst Initiation Summary
Bristol-Myers (BMY) initiated with a Hold at Deutsche Bank... ASML (ASML) initiated with a Hold at Stifel... Akamai (AKAM) initiated with an Outperform at RW Baird... Concur (CNQR) initiated with a Neutral at DA Davidson... CyrusOne (CONE) initiated with a Neutral at Citigroup... Eli Lilly (LLY) initiated with a Buy at Deutsche Bank... Garmin (GRMN) initiated with a Neutral at RW Baird... Merck (MRK) initiated with a Hold at Deutsche Bank... NetSuite (N) initiated with a Buy at DA Davidson... Oracle (ORCL) initiated with a Neutral at DA Davidson... Oxford Industries (OXM) initiated with a Buy at Wunderlich... Pfizer (PFE) initiated with a Buy at Deutsche Bank... ServiceNow (NOW) initiated with a Buy at DA Davidson... Workday (WDAY) initiated with a Neutral at DA Davidson... MannKind (MNKD) initiated with a Buy at Jefferies... STMicroelectronics (STM) initiated with an Underperform at Credit Suisse... Kirkland's (KIRK) initiated with an Outperform at Barrington.
09:53 EDTFBOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:53 EDTFBFacebook LiveRail buy could set up competition with Google, says William Blair
Subscribe for More Information
06:42 EDTBMYBristol-Myers initiated with a Hold at Deutsche Bank
Target $52.
06:36 EDTFBNordstrom, Target launching Instagram platform, CNBC says
Subscribe for More Information
06:07 EDTFBFacebook downgraded to Neutral from Buy at Janney Capital
Janney Capital downgraded Facebook to Neutral based on valuation and sees headwinds in 2015 from a deceleration in top-line growth, engagement, and monthly active users. Price target remains $82.50.
06:04 EDTFBSnapchat's valuation hits $10B, WSJ reports
Subscribe for More Information
05:54 EDTFBFacebook says did not acquire WaveGroup Sound, VentureBeat reports
Subscribe for More Information
05:44 EDTBMYBristol-Myers Daklinza approved by EC
Bristol-Myers announced that the European Commission, or EC, has approved Daklinza for use in combination with other medicinal products across genotypes 1, 2, 3 and 4 for the treatment of chronic hepatitis C virus, or HCV, infection in adults. Daklinza, when used in combination with sofosbuvir, is an all-oral, interferon-free regimen that provided cure rates of up to 100% in clinical trials, including patients with advanced liver disease, genotype 3 and those who have previously failed treatment with protease inhibitors. Daklinza is the first NS5A complex inhibitor approved in the European Union and will be available for use in combination with other medicinal products, providing a shorter treatment duration compared to 48 weeks of treatment with interferon- and ribavirin-based regimens. The approval allows for the marketing of Daklinza in all 28 Member States of the EU. The marketing authorization for Daklinza follows an accelerated assessment by the Committee for Medicinal Products for Human Use, a designation that is granted to new medicines of major public health interest.
August 26, 2014
11:55 EDTFBInstagram announces Hyperlapse from Instagram app
Instagram announced on its blog Hyperlapse from Instagram, "a new app to capture high-quality time lapse videos even while in motion. Traditionally, time lapse videos depend on holding your phone or camera still while you film. Hyperlapse from Instagram features built-in stabilization technology that lets you create moving, handheld time lapses that result in a cinematic look, quality and feel—a feat that has previously only been possible with expensive equipment." Reference Link
09:35 EDTFBActive equity options trading on open
Subscribe for More Information
August 25, 2014
13:06 EDTFBWhatsApp grows to 600M monthly active users
Subscribe for More Information
August 22, 2014
12:39 EDTBMYThese five companies will benefit from increased ALS awareness, MarketWatch says
A recent surge in funding for Lou Gehrig's disease, or ALS, caused by the Ice Bucket challenge that is widespread on social media outlets, will benefit five pharmaceutical companies that are involved in the development of a cure for ALS, according to MarketWatch. The companies that are or have been involved in developing a treatment for ALS include Biogen Idec (BIIB), Avanir Pharmaceuticals (AVNR), Isis Pharmaceuticals (ISIS), Sanofi (SNY), and Bristol-Myers Squibb (BMY), MarketWatch added. Reference Link
August 21, 2014
13:32 EDTBMYBristol-Myers, Pfizer announce approval of Eliquis for treatment of DVT, PE
Subscribe for More Information
12:59 EDTFBPrivacy lawsuit against Facebook draws support from 60,000 users, Reuters says
A class action lawsuit against Facebook Ireland, the division that runs the company's international business activities, has received support from more than 60,000 users and passed its first legal review, Reuters reports, citing the creator of the lawsuit, Australian law student Max Schrems. The lawsuit claims damages of $663 per Facebook user for alleged privacy violations. The Vienna Regional Court has ordered Facebook Ireland to respond to the claims made by the lawsuit within four weeks, Schrems added. Reference Link
August 20, 2014
09:36 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL FOLD TSLA TWTR WHX FB TM NFLX X EOG
08:03 EDTBMYBristol-Myers Pfizer to present new Eliquis data
Subscribe for More Information
08:02 EDTBMYBristol-Myers, Celgene enter collaboration agreement for OPDIVO, ABRAXANE
Subscribe for More Information
August 19, 2014
09:38 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD TSLA CELG VLO VZ FB HD
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use